Artificial Intelligence in Drug Discovery
Un pódcast de Simon Smith
12 Episodo
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Publicado: 7/8/2018 -
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Publicado: 7/8/2018 -
Regina Barzilay, AI Small Molecule Discovery and Synthesis
Publicado: 30/7/2018 -
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
Publicado: 26/7/2018 -
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
Publicado: 18/7/2018 -
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
Publicado: 10/7/2018 -
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Publicado: 28/6/2018 -
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
Publicado: 20/6/2018 -
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Publicado: 11/6/2018 -
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
Publicado: 29/5/2018 -
Mauro Cozzi, Researchably, AI for Better Biomedical Search
Publicado: 22/5/2018 -
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Publicado: 14/5/2018
1 / 1
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
